Click here for more information and to register.

Abstract submission and early bird registration are open till 1st of April.

During the NVGCT meeting, there will be a DARE-NL session. Trudy Straetemans will introduce DARE-NL and provide a presentation on the clinical development of TEG cells for cancer therapy, Edwin Bremer will provide a presentation on the academic lentiviral vector production platform in the Netherlands and Harry Dolstra will provide a presentation on the clinical development of CAR-NK cells for cancer therapy.